Gynecologists support a project currently under study to extend the boys' recommendation for the human papillomavirus (HPV) vaccine, viruses responsible for cervical cancer, to the FNCGM's national representative body, AFP.
"Universal vaccination (girls and boys ages 11 to 14, catching up to 19) would reduce the number of HPV-related cancers, with more population coverage," the CNNGM President, Dr Pia de Rilhac, told statement sent to AFP.
Adequate vaccination for young girls
In France, vaccination is now recommended and compensated for all girls between the ages of 11 and 14 and between the ages of 15 and 19 in the event of convergence. It is also recommended for men up to 26 years of age to have sex with men (MSM) and immunocompromised patients.
According to a draft opinion released on October 30, the High Health Authority (FAS) is considering extending this recommendation to young boys, "to stop the transmission" of HPV. The health authority was seized on the matter by the Ministry of Health.
"Medical gynecologists, following (the vote of) the National Federation of Colleges of Medical Gynecology (FNCGM), have given a very favorable opinion to this recommendation," the CNNGM said, subject to "public consultation" until November 27th.
Cancellations associated with papillomavirus
HPV-related sexually transmitted infections can cause years of cancer in women and men, the cervix, vagina, penis, anus or throat.
About 1,750 new cases of HVV related to cancer occur each year in France for men and 4,580 for women. The only cervical cancer still kills 1100 women each year in France and 900 new cases are diagnosed.
Some countries, such as the United States, already recommend that all predators be vaccinated against HPV at the age of 11 or 12 before being exposed to this viral risk.